Brokerages expect ASGN Inc (NYSE:ASGN) to post sales of $892.43 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for ASGN’s earnings. The lowest sales estimate is $891.77 million and the highest is $893.10 million. ASGN reported sales of $667.05 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 33.8%. The firm is expected to report its next quarterly earnings results on Wednesday, October 24th.

According to Zacks, analysts expect that ASGN will report full year sales of $3.34 billion for the current fiscal year, with estimates ranging from $3.34 billion to $3.35 billion. For the next year, analysts forecast that the business will report sales of $3.72 billion per share, with estimates ranging from $3.68 billion to $3.78 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for ASGN.

ASGN (NYSE:ASGN) last released its earnings results on Wednesday, July 25th. The business services provider reported $1.11 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.06. The company had revenue of $878.50 million during the quarter, compared to analysts’ expectations of $865.03 million. ASGN had a return on equity of 19.07% and a net margin of 5.67%. The business’s revenue was up 34.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.78 EPS.

ASGN has been the subject of several research analyst reports. Zacks Investment Research cut ASGN from a “buy” rating to a “hold” rating in a research note on Tuesday, April 17th. BMO Capital Markets reduced their target price on ASGN from $101.00 to $94.00 and set an “outperform” rating for the company in a research note on Thursday, April 26th. ValuEngine cut ASGN from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 1st. Robert W. Baird restated a “neutral” rating on shares of ASGN in a research note on Thursday, July 26th. Finally, Credit Suisse Group began coverage on ASGN in a research note on Friday. They set a “neutral” rating and a $92.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. ASGN has a consensus rating of “Buy” and an average price target of $84.00.

In related news, Director Arshad Matin sold 2,000 shares of the firm’s stock in a transaction on Monday, May 21st. The stock was sold at an average price of $84.62, for a total transaction of $169,240.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Peter T. Dameris sold 18,750 shares of the firm’s stock in a transaction on Monday, May 14th. The stock was sold at an average price of $82.44, for a total value of $1,545,750.00. Following the transaction, the chief executive officer now owns 151,621 shares in the company, valued at $12,499,635.24. The disclosure for this sale can be found here. Insiders have sold 46,437 shares of company stock worth $4,075,926 over the last 90 days. 3.90% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in ASGN. First Mercantile Trust Co. acquired a new stake in ASGN in the second quarter worth $113,000. Victory Capital Management Inc. acquired a new stake in ASGN in the second quarter worth $132,000. Winslow Evans & Crocker Inc. acquired a new stake in ASGN in the second quarter worth $154,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in ASGN in the second quarter worth $158,000. Finally, Trexquant Investment LP acquired a new stake in ASGN in the second quarter worth $201,000. Hedge funds and other institutional investors own 81.85% of the company’s stock.

Shares of ASGN stock traded down $0.56 on Tuesday, hitting $90.90. 201,107 shares of the company’s stock traded hands, compared to its average volume of 322,428. The stock has a market cap of $4.78 billion, a P/E ratio of 29.80, a price-to-earnings-growth ratio of 2.21 and a beta of 1.91. The company has a current ratio of 2.28, a quick ratio of 3.02 and a debt-to-equity ratio of 1.16. ASGN has a 52-week low of $44.66 and a 52-week high of $94.25.

ASGN Company Profile

ASGN Incorporated provides IT and professional services in the technology, digital, creative, healthcare technology, engineering, life sciences, and government sectors in the United States, Europe, and Canada. The company's Apex segment offers technical, digital, and creative and scientific professionals for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients; IT staffing and consulting services comprising IT infrastructure, application development, project management, and healthcare IT professionals; and creative, marketing, advertising, and digital professionals.

Recommended Story: Find a Trading Strategy That Works

Get a free copy of the Zacks research report on ASGN (ASGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for ASGN (NYSE:ASGN)

Receive News & Ratings for ASGN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASGN and related companies with MarketBeat.com's FREE daily email newsletter.